Alteon, Inc.
Records under this name other than patents Alteon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE38,330 | Preventing and reversing advanced glycosylation endproducts Term ended Ended no later than Jan 18, 2015 · From the USPTO record | Term ended | Ended no later than Jan 18, 2015 | From the USPTO record |
| US RE39,138 | Monoclonal antibody specific for advanced glycosylation endproducts in biological samples Term ended Term ended Dec 30, 2014 · From the USPTO record | Term ended | Term ended Dec 30, 2014 | From the USPTO record |
| US 7,026,342 | Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds Lapsed on the fee record Ended Apr 11, 2014 · From the USPTO record | Lapsed on the fee record | Ended Apr 11, 2014 | From the USPTO record |
| US 6,960,605 | Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging Lapsed on the fee record Ended Nov 1, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 1, 2013 | From the USPTO record |
| US 7,511,036 | Dihydrothiazine prodrugs of thiazolium agents Formerly held Lapsed on the fee record Ended Mar 31, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 31, 2013 | From the USPTO record |
| US 7,432,254 | Method for treating glaucoma IC Formerly held Lapsed on the fee record Ended Oct 7, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2012 | From the USPTO record |
| US 6,770,663 | Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds Lapsed on the fee record Ended Aug 3, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2012 | From the USPTO record |
| US 6,060,470 | Triazine compounds and methods of use therefor Lapsed on the fee record Ended May 9, 2012 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2012 | From the USPTO record |
| US 6,713,498 | Method for treating glaucoma VI Lapsed on the fee record Ended Mar 30, 2012 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2012 | From the USPTO record |
| US 6,025,401 | Method and agents for inhibiting protein aging Lapsed on the fee record Ended Feb 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2012 | From the USPTO record |